May 23 |
AbbVie Completes Acquisition of Landos Biopharma
|
Apr 26 |
Ex-Humira Growth Platform Drives AbbVie's Q1 Performance, Drugmaker Lifts Annual Profit Outlook
|
Mar 28 |
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
|
Mar 26 |
AbbVie (ABBV) to Buy Landos to Strengthen Autoimmune Portfolio
|
Mar 25 |
Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
|
Mar 25 |
Landos shares rocket 170% on AbbVie takeover deal
|
Mar 25 |
AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases
|
Mar 25 |
AbbVie to buy immune drug developer Landos
|
Mar 21 |
Landos Biopharma reports Q4 results
|
Mar 21 |
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
|